Your browser doesn't support javascript.
loading
Macular vessel reduction as predictor for recurrence of macular oedema requiring repeat intravitreal ranibizumab injection in eyes with branch retinal vein occlusion.
Hasegawa, Taiji; Takahashi, Yohei; Maruko, Ichiro; Kogure, Akiko; Iida, Tomohiro.
Afiliação
  • Hasegawa T; Department of Ophthalmology, Tokyo Women's Medical University, Tokyo, Japan hasegawa.taiji@twmu.ac.jp.
  • Takahashi Y; Department of Ophthalmology, Tokyo Women's Medical University, Tokyo, Japan.
  • Maruko I; Department of Ophthalmology, Tokyo Women's Medical University, Tokyo, Japan.
  • Kogure A; Department of Ophthalmology, Tokyo Women's Medical University, Tokyo, Japan.
  • Iida T; Department of Ophthalmology, Tokyo Women's Medical University, Tokyo, Japan.
Br J Ophthalmol ; 103(10): 1367-1372, 2019 10.
Article em En | MEDLINE | ID: mdl-30514711

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vasos Retinianos / Oclusão da Veia Retiniana / Edema Macular / Inibidores da Angiogênese / Ranibizumab / Macula Lutea Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vasos Retinianos / Oclusão da Veia Retiniana / Edema Macular / Inibidores da Angiogênese / Ranibizumab / Macula Lutea Idioma: En Ano de publicação: 2019 Tipo de documento: Article